These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17998873)

  • 1. Splenocytes can replace chimeric cells and maintain allograft tolerance.
    Hayashi Y; Yamazaki S; Kanamoto A; Takayama T
    Transplantation; 2007 Nov; 84(9):1168-73. PubMed ID: 17998873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partially MHC-matched donor CD8+ T cells are indispensable for switching to splenocytic chimerism.
    Kutsuna N; Yamazaki S; Kaiga T; Inagaki Y; Hayashi Y; Okada S; Kanamoto A; Takayama T
    J Surg Res; 2012 Jun; 175(1):62-6. PubMed ID: 21470627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric acceleration by donor CD4+CD25+T-reg depleted fraction in splenocyte transplantation.
    Kutsuna N; Yamazaki S; Kaiga T; Inagaki Y; Hayashi Y; Kanamoto A; Okada S; Takayama T
    J Surg Res; 2012 Nov; 178(1):133-8. PubMed ID: 22502904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic bone marrow-derived flk-1+Sca-1- mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance.
    Deng W; Han Q; Liao L; Li C; Ge W; Zhao Z; You S; Deng H; Zhao RC
    Exp Hematol; 2004 Sep; 32(9):861-7. PubMed ID: 15345288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of donor splenocytes with costimulation blockade to induce mixed hematopoietic chimerism and transplantation tolerance.
    Shirasugi N; Emmanouilidis N; Pearson TC; Larsen CP
    Transplant Proc; 2004 Oct; 36(8):2423-4. PubMed ID: 15561267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Jan; 144(2):463-73. PubMed ID: 2136891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
    J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term (>1 year) analyses of chimerism and tolerance in mixed allogeneic chimeric mice using normal mouse combinations.
    Hayashi H; Toki J; Zhexiong L; Sugiura K; Inoue K; Ikehara S
    Stem Cells; 2000; 18(4):273-80. PubMed ID: 10924093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
    Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD28 peptidemimic can induce mixed chimerism and prolong the survival of cardiac allografts.
    Chen J; He Q; Xu H; Su L; Zhang J; Xiong S
    Transpl Immunol; 2004 Dec; 13(4):283-8. PubMed ID: 15589741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infusion of donor hepatic non-parenchymal cells prolongs survival of skin allografts in mice: role of microchimerism and IL-4.
    Ding XM; Xue WJ; Ji ZZ; Tian PX
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):34-7. PubMed ID: 17287163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice.
    Yoshida A; Narumi S; Hashimoto N; Itabashi Y; Hakamada K; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2418-22. PubMed ID: 15561266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of donor bone marrow cell-derived chimerism in transplantation tolerance using transgenic mice.
    Smith JP; Kasten-Jolly J; Field LJ; Thomas JM
    Transplantation; 1994 Aug; 58(3):324-9. PubMed ID: 8053056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent acceptance of both cardiac and skin allografts using a mild conditioning regimen for the induction of stable mixed chimerism in mice.
    van Pel M; Hilbrands L; Smits D; van Breugel DW; van Eck M; Boog CJ
    Transpl Immunol; 2003; 11(1):57-63. PubMed ID: 12727476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of tolerance in quadruple chimeric mice.
    Fan TX; Hisha H; Jin TN; Sugiura K; Inaba M; Yang GX; Li Q; Wang XL; Song CY; Cui YZ; Li Q; Zhang Y; Zhang XG; Fan HX; Ikehara S
    Stem Cells; 2004; 22(5):683-95. PubMed ID: 15342933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lympho-myeloid chimerism achieved by spleen graft of green fluorescent protein transgenic rat in a combined pancreas transplantation model (TI03-029).
    Sakuma Y; Sato Y; Inoue S; Kaneko T; Hakamata Y; Takahashi M; Murakami T; Kobayashi E
    Transpl Immunol; 2004 Jan; 12(2):115-22. PubMed ID: 14967309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human interleukin-10 transduced fetal liver stem cells prolong survival of mouse skin and heart allografts.
    Hase T; Chargui J; Inori F; Yoshimura R; Sembeil R; Nakatani T; Touraine JL
    Transplant Proc; 2005; 37(1):287-8. PubMed ID: 15808621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.